English/中文

Grants

Throughout its history, the China Medical Board has adopted a policy of not accepting unsolicited grant proposals. Thus, inquiries or unsolicited proposals may not receive an expeditious reply. The rationale is straightforward—CMB's strategic grant-making is highly focused on targeted activities to advance its mission. In its earliest phase, the China Medical Board devoted nearly all of its financing to Peking Union Medical College. Since 1950, the China Medical Board’s grant-making has been targeted at key Chinese and Asian universities. CMB encourages international groups wishing to work in China to establish relationships directly with CMB-affiliated Chinese and Asian institutions.

Year/Grant no.sort ascending Grantee Program Amount
(2021)
21-441
Southeast Asia $100,000
  • Supporting Youth in Drug War-Affected Communities
  • January 01, 2021 to December 31, 2024
  • Southeast Asia
  • This project aims to promote meaningful youth engagement while forging partnerships with NGOs and CBOs actively involved in supporting drug war-affected communities.
  • Gideon Lasco
(2021)
21-440
Southeast Asia $100,000
  • Social Responsibility for Health Equity
  • January 01, 2022 to December 31, 2024
  • Southeast Asia
  • Project activities aim to support Siriraj Hospital and its business partners in identifying where and how it makes sense for companies to make socially responsible and impactful investments.
  • May Sripatanaskul
(2021)
21-439
Southeast Asia $100,000
  • Vietnam Equity Network
  • January 01, 2022 to December 31, 2023
  • Southeast Asia
  • The project will conduct a scoping review of stakeholders’ opinions about what equity is and how it can be promoted in a multisectoral collaboration, and also will identify and document good practices for equity actions.
  • Hoang Tu Anh
(2021)
21-438
Health Policy and Systems Sciences $400,000
  • Reducing infections and improving long term outcomes of very preterm infants in China
  • January 01, 2022 to December 31, 2026
  • China
  • The research team led by the Children’s Hospital of Fudan University will collaborate with other Chinese hospitals through the Chinese Neonatal Network (CHNN) to conduct research projects on neonatal healthcare in China.
(2021)
21-437
Health Policy and Systems Sciences $80,000
  • CMB-OC: Economic evaluation of integrated maternal and mental care for preventing perinatal depression in China
  • January 01, 2022 to December 31, 2024
  • China
  • This study aims to implement a time-driven activity-based model of integrated mental and maternal care (I2Mcare) for pregnant women in Chinese primary care settings to prevent perinatal depression, and to conduct economic evaluation and feasibility assessment of the model.
  • Xin WANG
(2021)
21-436
Health Policy and Systems Sciences $80,000
  • CMB-OC: Evaluating the emerging patterns of adolescent tobacco use in transitional China
  • January 01, 2022 to December 31, 2023
  • China
  • This project is designed to investigate the existence and socio-cultural mechanisms of emerging patterns of tobacco use among Chinese adolescents, highlighting their features for tobacco control policy recommendations.
  • Xiaozhao YANG
(2022)
21-435
Health Policy and Systems Sciences $80,000
  • CMB-OC: Digitized intervention to promote psychosocial wellbeing of children and adolescents of parents with severe mental illness
  • January 01, 2023 to December 31, 2024
  • China
  • The study aims to develop a web-based program to improve the mental health for Children of Parents with Mental Illnesses (COPMI) based on the Let’s Talk About Children intervention, and to assess its efficacy and cost-effectiveness.
  • Lili GUAN
(2021)
21-434
Health Policy and Systems Sciences $80,000
  • CMB-OC: Battling China’s childhood myopia epidemic: a pragmatic prevention strategy
  • January 01, 2022 to December 31, 2024
  • China
  • The study will use a mixed methods (quantitative and qualitative study) design with a multidisciplinary team to evaluate the implementation process of myopia intervention, expand the growing base of knowledge, and propose scalable strategies.
  • Yi SONG
(2021)
21-433
Health Policy and Systems Sciences $40,000
  • CMB-OC: Improving innovation and access to combination vaccines for children in China
  • January 01, 2022 to December 31, 2023
  • China
  • This study will provide a detailed and comprehensive analysis of China’s combination vaccines from innovation to access and identify the main factors that affect attitudes and behavior choices for combination vaccines.
  • Yangmu HUANG
(2021)
21-432
Health Policy and Systems Sciences $80,000
  • CMB-OC: The impact and economic evaluation of whole-school anti-bullying intervention in secondary schools
  • January 01, 2022 to December 31, 2024
  • China
  • This study aims to modify and develop a Chinese whole-school anti-bullying Intervention and evaluate its effectiveness and cost-effectiveness in order todevelop a generalized toolkit and policy recommendations.
  • Yankun SUN
(2021)
21-431
Health Policy and Systems Sciences $40,000
  • CMB-OC: Developing a screening tool for domestic violence (DV) against infertile women in China
  • January 01, 2022 to December 31, 2023
  • China
  • This study aims to develop a specific screening tool for DV against infertile women suitable for use in reproductive medicine clinics, and to investigate the prevalence, pattern, severity, and influencing factors of DV against infertile women.
  • Yuanyuan WANG
(2021)
21-430
Health Policy and Systems Sciences $40,000
  • CMB-OC: Prevent adolescents from using electronic cigarettes through market regulations
  • January 01, 2022 to December 31, 2023
  • China
  • The project aims to document features of e-cigarette retailers and examine adolescent awareness and perceptions of e-cigarette market regulation and expansion, as well as their impacts, as a basis for informing public health interventions and policies.
  • Yang WANG
(2021)
21-429
Health Policy and Systems Sciences $80,000
  • CMB-OC: Development of a family-centered supportive intervention for Chinese adolescents and parents with young-onset dementia
  • January 01, 2021 to December 31, 2024
  • China
  • This project is directed to adolescents (ages 16 to 19) whose parents have been diagnosed with young-onset dementia and and is designed to facilitate positive adjustments and improve their psychological wellbeing and quality of life.
  • Jing WANG
(2021)
21-428
Health Policy and Systems Sciences $80,000
  • CMB-OC: Cost-effectiveness, acceptability, and feasibility of screening for perinatal depression in maternal care
  • January 01, 2021 to December 31, 2024
  • China
  • The study will investigate the cost-effectiveness of different PND screening strategies based on a prospective cohort study with concurrent economic evaluation using decision-analytic modeling.
  • Di LIANG
(2021)
21-427
Health Policy and Systems Sciences $40,000
  • CMB-OC: Facilitating early integration of palliative care in pediatric oncology
  • January 01, 2022 to December 31, 2024
  • China
  • This project aims to development and implement a nurse-initiated conversation program for pediatric cancer patients, leading to  a standardized program
  • Lei CHENG
(2021)
21-426
Health Policy and Systems Sciences $80,000
  • CMB-OC: Feasibility, acceptability and effectiveness of “App-assisted home-based cardiac rehabilitation program” for children and adolescents with CHD
  • January 01, 2022 to December 31, 2024
  • China
  • A multicenter pragmatic randomized controlled trial with blinded outcome assessment will be used to test the feasibility, acceptability and effectiveness of the iHeart program for children and adolescents with chronic heart disease in China.
  • Weizhi ZHANG
(2021)
21-425
Health Policy and Systems Sciences $40,000
  • CMB-OC: Real-time monitoring of suicidality in depressive adolescents: a smartphone-based ecological momentary assessment study
  • January 01, 2022 to December 31, 2024
  • China
  • This research will explore real-time dynamics of suicidality and short-term predictors among depressive adolescents in China using smartphone-based ecological momentary assessment combined with wearable actigraphy.
  • Lu NIU
(2021)
21-424
Health Policy and Systems Sciences $80,000
  • CMB-OC: CAMP & WeChat-assisted model for prevention of diabetes among women with a history of GDM
  • January 01, 2022 to December 31, 2024
  • China
  • This research aims to finalize the CAMP protocol using a mixed-method design in a pilot study; conduct CAMP program, ILSM program and usual care, and compare efficacy outcomes among women with a history of GDM.
  • Jia GUO
(2021)
21-423
Health Policy and Systems Sciences $40,000
  • CMB-OC: Long-term outcomes of an RCT of transvaginal surgery with synthetic mesh
  • January 01, 2022 to February 22, 2023
  • China
  • This study will collect longer-term data on clinical and quality-of-life outcomes for subjects who completed the previous randomized control trial on the long-term efficacy and safety of transvaginal mesh.
  • Juan CHEN
(2021)
21-422
Health Policy and Systems Sciences $80,000
  • CMB-OC: Building an AI-assisted prediction model and clinical decision support system for management of pregnancy women with CKD
  • January 01, 2022 to December 31, 2024
  • China
  • This research will investigate the awareness and knowledge of multiple stakeholders regarding pregnancies in women with chronic kidney disease, and to develop a clinical decision support system.
  • Peng XIA
(2021)
21-421
Health Policy and Systems Sciences $80,000
  • CMB-OC: Develop a comprehensive breast cancer risk prediction model for Chinese women based on genetic test
  • January 01, 2022 to December 31, 2024
  • China
  • This research aims to develop the first comprehensive breast cancer risk prediction model for Chinese women incorporating multigenerational family history and genetic risk factors with conventional risk factors.
  • Xin HUANG
(2021)
21-420
Health Policy and Systems Sciences $80,000
  • CMB-OC: Single-dose domestic bivalent HPV16/18 vaccination impact on vaccine efficacy and cervical cancer screening among young adult women in China
  • January 01, 2022 to December 31, 2024
  • China
  • A randomized, blinded trial to assess the efficacy of a single-dose regimen of a domestic HPV vaccine against HPV-16/18 incident infections that persist six months or longer, in Chinese women ages 18-26.
  • Shangying HU
(2021)
21-419
Health Policy and Systems Sciences $40,000
  • CMB-OC: Effectiveness of a cognitive behavior therapy based digital intervention for Chinese women with perinatal depression
  • January 01, 2022 to December 31, 2024
  • China
  • This project aims to develop a CBT-based digital intervention program and evaluate the effectiveness of this program on Chinese women with perinatal depression.
  • Lei YANG
(2021)
21-418
Health Policy and Systems Sciences $40,000
  • CMB-OC: M-Health: a method to improve the screening and care for autism spectrum disorder in toddlers
  • January 01, 2022 to December 31, 2024
  • China
  • This project, which will be embedded in the Early Life Plan (ELP) conducted in Shanghai and Haikou, aims to develop a feasible and efficient ASD digital screening system suitable for use in primary care.
  • Hui WANG
(2021)
21-417
Health Policy and Systems Sciences $40,000
  • CMB-OC: Improving the quality of postpartum health in China through the multidisciplinary team approach
  • January 01, 2022 to December 31, 2023
  • China
  • This study aims to understand the health needs of women and infants in the postpartum period, identify groups at higher risk, and build and evaluate a multidisciplinary team model for postpartum care.
  • Ai ZHAO

Pages